{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:58:57Z","timestamp":1788260337923,"version":"build-2803163510"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Diabetic foot ulcers (DFU) are one of the most serious complications in\ndiabetic health treatment. The treatment for DFUs is more challenging, especially in individuals\nwith a weakened immune system. Furthermore, due to developing antibiotic resistance characteristics\namong harmful bacteria and fungi, existing antibiotics may not be helpful in combating microbial\ninfections in the wound site.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This review will focus on the newest advances in antimicrobial treatments, such as\ndressings and topical therapies, as well as drugs and debridement methods.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The English-language publications published on DFU were collected from a variety of\nsources, including Scopus, Web of Science, Bentham Science, Science Direct, and Google Scholar.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>DFU therapy necessitates a multidisciplinary strategy including the use of appropriate diagnostic\ninstruments, expertise, and experience. This begins with patient education and the use of\nnew classifications to direct care in order to avoid amputations. To gain a deeper understanding of\nthe microbiota in DFUs, new diagnostic approaches, such as the 16S ribosomal DNA sequence in\nbacteria, should become usable.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>DFU is said to have a polymicrobial nature and, depending on its geographical area,\nsome distinct characteristics, such as wound characteristics, antibiograms based on local epidemiology,\nindividualized antimicrobial driven treatment, routine debridement, regular wound examination,\nand dressing changes. New biological and molecular therapies that have been shown to enhance\ninfection prevention, the management of the local inflammatory profile, and the efficiency\nof the cicatrizing mechanism often help with the above characteristics.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399818666220228161608","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T05:54:38Z","timestamp":1646114078000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antimicrobial Remedies and Emerging Strategies for the Treatment of\nDiabetic Foot Ulcers"],"prefix":"10.2174","volume":"19","author":[{"given":"Yogeeta O.","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra,\n425405, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra,\n425405, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"883","volume":"13","author":"Jim&#xE9;nez P.G.","year":"2020","unstructured":"Jim&#xE9;nez P.G.; Mart&#xED;n-Carmona J.; Hern&#xE1;ndez E.L.; Diabetes mellitus. Med 2020,13(16),883-890","journal-title":"Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-09841-8","author":"Poretsky L.","year":"2010","unstructured":"Poretsky L.;  Principles of Diabetes Mellitus 2010,1-887","journal-title":"Principles of Diabetes Mellitus"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"9317987","DOI":"10.1155\/2018\/9317987","volume":"2018","author":"Aynalem S.B.","year":"2018","unstructured":"Aynalem S.B.; Zeleke A.J.; Prevalence of diabetes mellitus and its risk factors among individuals aged 15 years and above in Mizan-Aman Town, Southwest Ethiopia, 2016: A cross sectional study. Int J Endocrinol 2018,2018,9317987","journal-title":"Int J Endocrinol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2147\/DMSO.S225854","volume":"12","author":"Endris T.","year":"2019","unstructured":"Endris T.; Worede A.; Asmelash D.; Prevalence of diabetes mellitus, prediabetes and its associated factors in Dessie town, northeast Ethiopia: A community-based study. Diabetes. Diabetes Metab Syndr Obes 2019,12,2799-2809","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=5","first-page":"126","volume":"16","author":"Nugroho P.S.","year":"2020","unstructured":"Nugroho P.S.; Tianingrum N.A.; Sunarti S.; Rachman A.; Fahrurodzi D.S.; Amiruddin R.; Predictor risk of diabetes mellitus in Indonesia, based on national health survey. Malaysian J Med Health Sci 2020,16,126-130","journal-title":"Malaysian J Med Health Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1389450118666170704132523","volume":"19","author":"Hussain Z.","year":"2018","unstructured":"Hussain Z.; Thu H.E.; Shuid A.N.; Katas H.; Hussain F.; Recent advances in polymer-based wound dressings for the treatment of diabetic foot ulcer: An overview of state-of-the-art. Curr Drug Targets 2018,19(5),527-550","journal-title":"Curr Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1016\/j.actbio.2013.03.033","volume":"9","author":"Moura L.I.F.","year":"2013","unstructured":"Moura L.I.F.; Dias A.M.A.; Carvalho E.; de Sousa H.C.; Recent advances on the development of wound dressings for diabetic foot ulcer treatment-a review. Acta Biomater 2013,9(7),7093-7114","journal-title":"Acta Biomater"},{"key":"ref=8","first-page":"2S","volume":"15","author":"Li W.W.","year":"2003","unstructured":"Li W.W.; Li V.W.; Therapeutic angiogenesis for wound healing. Wounds 2003,15(9),2S-12S","journal-title":"Wounds"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/21691401.2012.716065","volume":"41","author":"Singh M.R.","year":"2013","unstructured":"Singh M.R.; Saraf S.; Vyas A.; Jain V.; Singh D.; Innovative approaches in wound healing: Trajectory and advances. Artif Cells Nanomed Biotechnol 2013,41(3),202-212","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"Singh N.","year":"2005","unstructured":"Singh N.; Armstrong D.G.; Lipsky B.A.; Preventing foot ulcers in patients with diabetes. JAMA 2005,293(2),217-228","journal-title":"JAMA"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.36502\/2019\/droa.6152","volume":"1","author":"Ruke MG","year":"2019","unstructured":"Ruke MG; Savai J; Diabetic foot infection, biofilm and new management strategy. Diabetes Res Open Access 2019,1(1),7-22","journal-title":"Diabetes Res Open Access"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4239\/wjd.v6.i1.37","volume":"6","author":"Yazdanpanah L.","year":"2015","unstructured":"Yazdanpanah L.; Nasiri M.; Adarvishi S.; Literature review on the management of diabetic foot ulcer. World J Diabetes 2015,6(1),37-53","journal-title":"World J Diabetes"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"Armstrong D.G.","year":"2017","unstructured":"Armstrong D.G.; Boulton A.J.M.; Bus S.A.; Diabetic foot ulcers and their recurrence. N Engl J Med 2017,376(24),2367-2375","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"Zhang P.","year":"2017","unstructured":"Zhang P.; Lu J.; Jing Y.; Tang S.; Zhu D.; Bi Y.; Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis \u2020. Ann Med 2017,49(2),106-116","journal-title":"Ann Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2337\/dc17-1836","volume":"41","author":"Jeffcoate W.J.","year":"2018","unstructured":"Jeffcoate W.J.; Vileikyte L.; Boyko E.J.; Armstrong D.G.; Boulton A.J.M.; Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care 2018,41(4),645-652","journal-title":"Diabetes Care"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2337\/diacare.24.1.84","volume":"24","author":"Oyibo S.O.","year":"2001","unstructured":"Oyibo S.O.; Jude E.B.; Tarawneh I.; Nguyen H.C.; Harkless L.B.; Boulton A.J.M.; A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001,24(1),84-88","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"Whiting D.R.","year":"2011","unstructured":"Whiting D.R.; Guariguata L.; Weil C.; Shaw J.; IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011,94(3),311-321","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1464-5491.2004.01358.x","volume":"21","author":"Eldor R.","year":"2004","unstructured":"Eldor R.; Raz I.; Ben Yehuda A.; Boulton A.J.M.; New and experimental approaches to treatment of diabetic foot ulcers: A comprehensive review of emerging treatment strategies. Diabet Med 2004,21(11),1161-1173","journal-title":"Diabet Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"21.e1","DOI":"10.1016\/j.jaad.2013.07.048","volume":"70","author":"Alavi A.","year":"2014","unstructured":"Alavi A.; Sibbald R.G.; Mayer D.; Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol 2014,70,21.e1-21.e24","journal-title":"J Am Acad Dermatol"},{"key":"ref=20","author":"McCulloch J.M.","year":"2010","unstructured":"McCulloch J.M.; Kloth L.;  Wound Healing: Evidence-Based Management (Contemporary Perspectives in Rehabilitation) 2010","journal-title":"Wound Healing: Evidence-Based Management (Contemporary Perspectives in Rehabilitation)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11648\/j.ijde.20180302.11","volume":"3","author":"Muhammad Ibrahim A.","year":"2018","unstructured":"Muhammad Ibrahim A.; Diabetic foot ulcer: Synopsis of the epidemiology and pathophysiology. Int J Diabetes Endocrinol 2018,3(2),23","journal-title":"Int J Diabetes Endocrinol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.18203\/2320-6012.ijrms20174548","volume":"5","author":"Rosyid F.N.","year":"2017","unstructured":"Rosyid F.N.; Etiology, pathophysiology, diagnosis and management of diabetics\u2019 foot ulcer. Int J Res Med Sci 2017,5(10),4206","journal-title":"Int J Res Med Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"012161","DOI":"10.1088\/1755-1315\/125\/1\/012161","volume":"125","author":"Syafril S.","year":"2018","unstructured":"Syafril S.; Pathophysiology diabetic foot ulcer. IOP Conf Ser: Earth Environ Sci 2018,125,012161","journal-title":"IOP Conf Ser: Earth Environ Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1.e1","DOI":"10.1016\/j.jaad.2013.06.055","volume":"70","author":"Alavi A.","year":"2014","unstructured":"Alavi A.; Sibbald R.G.; Mayer D.; Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol 2014,70(1),1.e1-1.e18","journal-title":"J Am Acad Dermatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.JAA.0000464276.44117.b1","volume":"28","author":"Aumiller W.D.","year":"2015","unstructured":"Aumiller W.D.; Dollahite H.A.; Pathogenesis and management of diabetic foot ulcers. JAAPA 2015,28(5),28-34","journal-title":"JAAPA"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.18203\/2394-6040.ijcmph20184249","volume":"5","author":"Alsanawi Y.","year":"2018","unstructured":"Alsanawi Y.; Alismail H.; Pathogenesis and management of diabetic foot ulcers. Int J Community Med Public Health 2018,5(11),4953","journal-title":"Int J Community Med Public Health"},{"key":"ref=27","first-page":"1655","volume":"66","author":"Frykberg R.G.","year":"2002","unstructured":"Frykberg R.G.; Diabetic foot ulcers: pathogenesis and management. Am Fam Physician 2002,66(9),1655-1662","journal-title":"Am Fam Physician"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.dsx.2019.01.048","volume":"13","author":"Megallaa M.H.","year":"2019","unstructured":"Megallaa M.H.; Ismail A.A.; Zeitoun M.H.; Khalifa M.S.; Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes. Diabetes Metab Syndr 2019,13(2),1287-1292","journal-title":"Diabetes Metab Syndr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.acvd.2015.01.015","volume":"108","author":"Esteghamati A.","year":"2015","unstructured":"Esteghamati A.; Aflatoonian M.; Rad M.V.; Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. Arch Cardiovasc Dis 2015,108(8-9),412-419","journal-title":"Arch Cardiovasc Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.18203\/2349-2902.isj20170937","volume":"4","author":"Muthiah A.","year":"2017","unstructured":"Muthiah A.; Kandasamy R.; Madasamy A.; A study on diabetic foot and its association with peripheral artery disease. Int Surg J 2017,4(4),1217","journal-title":"Int Surg J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1002\/dmrr.464","volume":"20","author":"Schaper N.C.","year":"2004","unstructured":"Schaper N.C.; Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004,20(SUPPL. 1),S90-S95","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jid.2016.08.009","volume":"137","author":"Loesche M.","year":"2017","unstructured":"Loesche M.; Gardner S.E.; Kalan L.; Temporal stability in chronic wound microbiota is associated with poor healing. J Invest Dermatol 2017,137(1),237-244","journal-title":"J Invest Dermatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e002370","DOI":"10.1136\/bmjopen-2012-002370","volume":"3","author":"Nelson E.A.","year":"2013","unstructured":"Nelson E.A.; Backhouse M.R.; Bhogal M.S.; Concordance in diabetic foot ulcer infection. BMJ Open 2013,3(1),e002370","journal-title":"BMJ Open"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e019437","DOI":"10.1136\/bmjopen-2017-019437","volume":"8","author":"Nelson A.","year":"2018","unstructured":"Nelson A.; Wright-Hughes A.; Backhouse M.R.; CODIFI (Concordance in Diabetic Foot Ulcer Infection): A cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England. BMJ Open 2018,8(1),e019437","journal-title":"BMJ Open"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/iwj.13465","volume":"17","author":"Jouhar L.","year":"2020","unstructured":"Jouhar L.; Jaafar R.F.; Nasreddine R.; Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon. Int Wound J 2020,17(6),1764-1773","journal-title":"Int Wound J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humic.2017.09.002","volume":"5-6","author":"Jneid J.","year":"2017","unstructured":"Jneid J.; Lavigne J.P.; La Scola B.; Cassir N.; The diabetic foot microbiota: A review. Hum Microbiome J 2017,5-6,1-6","journal-title":"Hum Microbiome J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3389\/fmicb.2017.01791","volume":"8","author":"Pereira S.G.","year":"2017","unstructured":"Pereira S.G.; Moura J.; Carvalho E.; Empadinhas N.; Microbiota of chronic diabetic wounds: Ecology, impact, and potential for innovative treatment strategies. Front Microbiol 2017,8,1791","journal-title":"Front Microbiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1742-481X.2007.00363.x","volume":"4","author":"Mart&#xED;nez-De Jes&#xFA;s F.R.","year":"2007","unstructured":"Mart&#xED;nez-De Jes&#xFA;s F.R.; Ramos-De la Medina A.; Remes-Troche J.M.; Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections. Int Wound J 2007,4(4),353-362","journal-title":"Int Wound J"},{"key":"ref=39","first-page":"431","volume":"23","author":"Liu P.Y.","year":"2012","unstructured":"Liu P.Y.; Shi Z.Y.; Sheu W.H.H.; Diagnosis and treatment of diabetic foot infections. J Intern Med Taiwan 2012,23(6),431-441","journal-title":"J Intern Med Taiwan"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.pmr.2009.06.007","volume":"20","author":"Miller A.O.","year":"2009","unstructured":"Miller A.O.; Henry M.; Update in diagnosis and treatment of diabetic foot infections. Phys Med Rehabil Clin N Am 2009,20(4),611-625","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1099\/jmm.0.076034-0","volume":"63","author":"Murali T.S.","year":"2014","unstructured":"Murali T.S.; Kavitha S.; Spoorthi J.; Characteristics of microbial drug resistance and its correlates in chronic diabetic foot ulcer infections. J Med Microbiol 2014,63(Pt 10),1377-1385","journal-title":"J Med Microbiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4103\/ijem.IJEM_546_16","volume":"21","author":"Jain S.K.","year":"2017","unstructured":"Jain S.K.; Barman R.; Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India. Indian J Endocrinol Metab 2017,21(5),688-694","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jiph.2015.10.011","volume":"9","author":"Karmaker M.","year":"2016","unstructured":"Karmaker M.; Sanyal S.K.; Sultana M.; Hossain M.A.; Association of bacteria in diabetic and non-diabetic foot infection - An investigation in patients from Bangladesh. J Infect Public Health 2016,9(3),267-277","journal-title":"J Infect Public Health"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12866-016-0665-z","volume":"16","author":"Smith K.","year":"2016","unstructured":"Smith K.; Collier A.; Townsend E.M.; One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers. BMC Microbiol 2016,16(1),54","journal-title":"BMC Microbiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8101580","volume":"8","author":"Pouget C.","year":"2020","unstructured":"Pouget C.; Dunyach-Remy C.; Pantel A.; Schuldiner S.; Sotto A.; Lavigne J.P.; Biofilms in diabetic foot ulcers: Significance and clinical relevance. Microorganisms 2020,8(10),1-15","journal-title":"Microorganisms"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3201\/eid0809.020063","volume":"8","author":"Donlan R.M.","year":"2002","unstructured":"Donlan R.M.; Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002,8(9),881-890","journal-title":"Emerg Infect Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i5.10","volume":"24","author":"Jain A.","year":"2007","unstructured":"Jain A.; Gupta Y.; Agrawal R.; Khare P.; Jain S.K.; Biofilms-a microbial life perspective: A critical review. Crit Rev Ther Drug Carrier Syst 2007,24(5),393-443","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=48","first-page":"15","volume":"10","author":"Bhinu V.S.","year":"2006","unstructured":"Bhinu V.S.; Insight into biofilm-associated microbial life. J Mol Microbiol Biotechnol 2006,10,15-21","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref=49","author":"Santos R.","year":"2016","unstructured":"Santos R.; Veiga A.S.; Tavares L.; Castanho M.; Oliveira M.; Bacterial biofilms in diabetic foot ulcers: Potential alternative therapeutics. Microbial Biofilms - Importance and Applications 2016","journal-title":"Microbial Biofilms - Importance and Applications"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.2337\/db15-0031","volume":"64","author":"Messad N.","year":"2015","unstructured":"Messad N.; Prajsnar T.K.; Lina G.; Existence of a colonizing Staphylococcus aureus strain isolated in diabetic foot ulcers. Diabetes 2015,64(8),2991-2995","journal-title":"Diabetes"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","volume":"8","author":"Sharma D.","year":"2019","unstructured":"Sharma D.; Misba L.; Khan A.U.; Antibiotics versus biofilm: An emerging battleground in microbial communities. Antimicrob Resist Infect Control 2019,8,76","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1534734619873785","volume":"19","author":"Srivastava P.","year":"2020","unstructured":"Srivastava P.; Sivashanmugam K.; Combinatorial drug therapy for controlling Pseudomonas aeruginosa and its association with chronic condition of diabetic foot ulcer. Int J Low Extrem Wounds 2020,19(1),7-20","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/iwj.12777","volume":"14","author":"Johani K.","year":"2017","unstructured":"Johani K.; Malone M.; Jensen S.; Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers. Int Wound J 2017,14(6),1160-1169","journal-title":"Int Wound J"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3389\/fmicb.2015.01464","volume":"6","author":"Shahi S.K.","year":"2016","unstructured":"Shahi S.K.; Kumar A.; Isolation and genetic analysis of multidrug resistant bacteria from diabetic foot ulcers. Front Microbiol 2016,6(JAN),1464","journal-title":"Front Microbiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1534734614521236","volume":"13","author":"Ji X.","year":"2014","unstructured":"Ji X.; Jin P.; Chu Y.; Feng S.; Wang P.; Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. Int J Low Extrem Wounds 2014,13(1),64-71","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=56","first-page":"22","volume":"2","author":"Zubair M.","year":"2010","unstructured":"Zubair M.; Malik A.; Ahmad J.; Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India. Biol Med (Aligarh) 2010,2(4),22-34","journal-title":"Biol Med (Aligarh)"},{"key":"ref=57","volume":"2017","author":"Xie X","year":"2017","unstructured":"Xie X; Bao Y; Ni L; Liu D; Niu S; Lin H; bacterial profile and antibiotic resistance in patients with diabetic foot ulcer in Guangzhou, southern china: focus on the differences among different Wagner\u2019s grades, IDSA\/IWGDF grades, and ulcer types. Int J Endocrinol 2017,2017","journal-title":"Int J Endocrinol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4102\/ajlm.v10i1.1261","volume":"10","author":"Adeyemo A.T.","year":"2021","unstructured":"Adeyemo A.T.; Kolawole B.; Rotimi V.O.; Aboderin A.O.; Multicentre study of the burden of multidrug-resistant bacteria in the aetiology of infected diabetic foot ulcers. Afr J Lab Med 2021,10(1),1261","journal-title":"Afr J Lab Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/jcm10091948","volume":"10","author":"Matta-Guti&#xE9;rrez G.","year":"2021","unstructured":"Matta-Guti&#xE9;rrez G.; Garc&#xED;a-Morales E.; Garc&#xED;a-&#xC1;lvarez Y.; &#xC1;lvaro-Afonso F.J.; Molines-Barroso R.J.; L&#xE1;zaro-Mart&#xED;nez J.L.; The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: A systematic review. J Clin Med 2021,10(9),1948","journal-title":"J Clin Med"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AIDDMRR139>3.0.CO;2-8","volume":"16","author":"Apelqvist J","year":"2000","unstructured":"Apelqvist J; Larsson J; What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000,16(SUPPL. 1)","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0732-8893(02)00377-2","volume":"43","author":"Balows A.","year":"2002","unstructured":"Balows A.; Molecular medical microbiology. Diagn Microbiol Infect Dis 2002,43(2),173-174","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2015.24.Sup5b.20","volume":"24","author":"Tayeb K.A.","year":"2015","unstructured":"Tayeb K.A.; Managing infection: A holistic approach. J Wound Care 2015,24(5)(Suppl. 2),20-30","journal-title":"J Wound Care"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/wound.2011.0333","volume":"1","author":"Attinger C.","year":"2012","unstructured":"Attinger C.; Wolcott R.; Clinically addressing biofilm in chronic wounds. Adv Wound Care (New Rochelle) 2012,1(3),127-132","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/iwj.13509","volume":"18","author":"Kataoka Y.","year":"2021","unstructured":"Kataoka Y.; Kunimitsu M.; Nakagami G.; Koudounas S.; Weller C.D.; Sanada H.; Effectiveness of ultrasonic debridement on reduction of bacteria and biofilm in patients with chronic wounds: A scoping review. Int Wound J 2021,18(2),176-186","journal-title":"Int Wound J"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/CWCMR.S127874","volume":"4","author":"Yarets Y.","year":"2017","unstructured":"Yarets Y.; Effective biofilm removal and changes in bacterial biofilm building capacity after wound debridement with low-frequency ultrasound as part of wound bed preparation before skin grafting. Chronic Wound Care Manag Res 2017,4,55-64","journal-title":"Chronic Wound Care Manag Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.engreg.2020.07.003","volume":"1","author":"Dhar Y.","year":"2020","unstructured":"Dhar Y.; Han Y.; Current developments in biofilm treatments: Wound and implant infections. Eng Regen 2020,1,64-75","journal-title":"Eng Regen"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.12968\/jowc.2015.24.8.366","volume":"24","author":"Wolcott R.","year":"2015","unstructured":"Wolcott R.; Disrupting the biofilm matrix improves wound healing outcomes. J Wound Care 2015,24(8),366-371","journal-title":"J Wound Care"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/13696998.2017.1423489","volume":"21","author":"Dreyfus J.","year":"2018","unstructured":"Dreyfus J.; Delhougne G.; James R.; Gayle J.; Waycaster C.; Clostridial collagenase ointment and medicinal honey utilization for pressure ulcers in US hospitals. J Med Econ 2018,21(4),390-397","journal-title":"J Med Econ"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/cer-2017-0066","volume":"7","author":"Waycaster C.","year":"2018","unstructured":"Waycaster C.; Carter M.J.; Gilligan A.M.; Mearns E.S.; Fife C.E.; Milne C.T.; Comparative cost and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers. J Comp Eff Res 2018,7(2),149-165","journal-title":"J Comp Eff Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12090881","volume":"12","author":"Naomi R.","year":"2020","unstructured":"Naomi R.; Fauzi M.B.; Cellulose\/collagen dressings for diabetic foot ulcer: A review. Vol. 12. Pharmaceutics 2020,12(9),1-18","journal-title":"Pharmaceutics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/1753-0407.12871","volume":"11","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Sun D.; Jiang G.C.; Comparative efficacy of nine different dressings in healing diabetic foot ulcer: A Bayesian network analysis. J Diabetes 2019,11(6),418-426","journal-title":"J Diabetes"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"CD009099","DOI":"10.1002\/14651858.CD009099.pub3","volume":"2013","author":"Dumville J.C.","year":"2013","unstructured":"Dumville J.C.; Deshpande S.; O\u2019Meara S.; Speak K.; Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2013,2013(8),CD009099","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3947\/ic.2018.50.1.11","volume":"50","author":"Kwon K.T.","year":"2018","unstructured":"Kwon K.T.; Armstrong D.G.; Microbiology and antimicrobial therapy for diabetic foot infections. Infect Chemother 2018,50(1),11-20","journal-title":"Infect Chemother"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/ijmr.IJMR_1436_14","volume":"145","author":"Haldar J.","year":"2017","unstructured":"Haldar J.; Mukherjee P.; Mukhopadhyay S.; Maiti P.K.; Isolation of bacteria from diabetic foot ulcers with special reference to anaerobe isolation by simple two-step combustion technique in candle jar. Indian J Med Res 2017,145(1),97-101","journal-title":"Indian J Med Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(05)67694-5","volume":"366","author":"Lipsky B.A.","year":"2005","unstructured":"Lipsky B.A.; Armstrong D.G.; Citron D.M.; Tice A.D.; Morgenstern D.E.; Abramson M.A.; Ertapenem versus piperacillin\/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005,366(9498),1695-1703","journal-title":"Lancet"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.semvascsurg.2012.04.010","volume":"25","author":"Roberts A.D.","year":"2012","unstructured":"Roberts A.D.; Simon G.L.; Diabetic foot infections: The role of microbiology and antibiotic treatment. Semin Vasc Surg 2012,25(2),75-81","journal-title":"Semin Vasc Surg"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1185\/03007995.2015.1128888","volume":"32","author":"Karri V.V.S.R.","year":"2016","unstructured":"Karri V.V.S.R.; Kuppusamy G.; Talluri S.V.; Yamjala K.; Mannemala S.S.; Malayandi R.; Current and emerging therapies in the management of diabetic foot ulcers. Curr Med Res Opin 2016,32(3),519-542","journal-title":"Curr Med Res Opin"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s13346-017-0445-9","volume":"8","author":"Ahmed A.","year":"2018","unstructured":"Ahmed A.; Getti G.; Boateng J.; Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. Drug Deliv Transl Res 2018,8(6),1751-1768","journal-title":"Drug Deliv Transl Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.12968\/jowc.2013.22.3.130","volume":"22","author":"Yingsakmongkol N.","year":"2013","unstructured":"Yingsakmongkol N.; Clinical outcomes of WF10 adjunct to standard treatment of diabetic foot ulcers. J Wound Care 2013,22(3),130-132, 134-136","journal-title":"J Wound Care"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3159798","DOI":"10.1155\/2017\/3159798","volume":"2017","author":"Gasca-Lozano L.E.","year":"2017","unstructured":"Gasca-Lozano L.E.; Lucano-Landeros S.; Ruiz-Mercado H.; Pirfenidone accelerates wound healing in chronic diabetic foot ulcers: A randomized, double-blind controlled trial. J Diabetes Res 2017,2017,3159798","journal-title":"J Diabetes Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2015.06.029","volume":"764","author":"Ram M.","year":"2015","unstructured":"Ram M.; Singh V.; Kumawat S.; Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. Eur J Pharmacol 2015,764,9-21","journal-title":"Eur J Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.semcdb.2012.09.014","volume":"23","author":"Maderal A.D.","year":"2012","unstructured":"Maderal A.D.; Vivas A.C.; Eaglstein W.H.; Kirsner R.S.; The FDA and designing clinical trials for chronic cutaneous ulcers. Semin Cell Dev Biol 2012,23(9),993-999","journal-title":"Semin Cell Dev Biol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1517\/14728214.2013.802305","volume":"18","author":"Tecilazich F.","year":"2013","unstructured":"Tecilazich F.; Dinh T.L.; Veves A.; Emerging drugs for the treatment of diabetic ulcers. Expert Opin Emerg Drugs 2013,18(2),207-217","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"105931","DOI":"10.1016\/j.ijscr.2021.105931","volume":"82","author":"Parizad N.","year":"2021","unstructured":"Parizad N.; Hajimohammadi K.; Goli R.; Surgical debridement, maggot therapy, negative pressure wound therapy, and silver foam dressing revive hope for patients with diabetic foot ulcer: A case report. Int J Surg Case Rep 2021,82,105931","journal-title":"Int J Surg Case Rep"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dsx.2021.01.014","volume":"15","author":"Maranna H.","year":"2021","unstructured":"Maranna H.; Lal P.; Mishra A.; Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study. Diabetes Metab Syndr 2021,15(1),365-371","journal-title":"Diabetes Metab Syndr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"104100","DOI":"10.1016\/j.mvr.2020.104100","volume":"133","author":"Fin&#x17E;gar M.","year":"2021","unstructured":"Fin&#x17E;gar M.; Frange&#x17E; H.B.; Cankar K.; Frange&#x17E; I.; Transcutaneous application of the gaseous CO2 for improvement of the microvascular function in patients with diabetic foot ulcers. Microvasc Res 2021,133,104100","journal-title":"Microvasc Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"110548","DOI":"10.1016\/j.mehy.2021.110548","volume":"149","author":"Fang J.","year":"2021","unstructured":"Fang J.; Xu J.; Zhang Y.; Stromal cell-derived factor-1 may play pivotal role in distraction-stimulated neovascularization of diabetic foot ulcer. Med Hypotheses 2021,149,110548","journal-title":"Med Hypotheses"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.tem.2020.10.003","volume":"31","author":"Shao S.","year":"2020","unstructured":"Shao S.; Pan R.; Chen Y.; Autologous platelet-rich plasma for diabetic foot ulcer. Trends Endocrinol Metab 2020,31(12),885-890","journal-title":"Trends Endocrinol Metab"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fas.2020.08.002","volume":"27","author":"Uzun E.","year":"2021","unstructured":"Uzun E.; G&#xFC;ney A.; G&#xF6;nen Z.B.; Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I\/2 safety study. Foot Ankle Surg 2021,27(6),636-642","journal-title":"Foot Ankle Surg"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"108743","DOI":"10.1016\/j.diabres.2021.108743","volume":"174","author":"He S.","year":"2021","unstructured":"He S.; Liang C.; Yi C.; Wu M.; Therapeutic effect of continuous diffusion of oxygen therapy combined with traditional moist wound dressing therapy in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2021,174,108743","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpra.2021.04.012","volume":"30","author":"Terabe Y.","year":"2021","unstructured":"Terabe Y.; Kaneko N.; Nakabayashi K.; Matsui A.; Ando H.; Long-term efficient management of diabetic foot ulcer using simultaneous foot ulcer closure and surgical off-loading. JPRAS Open 2021,30,1-5","journal-title":"JPRAS Open"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.meegid.2021.104824","volume":"92","author":"Srivastava P.","year":"2021","unstructured":"Srivastava P.; Sivashanmugam K.; Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients. Infect Genet Evol 2021,92,104824","journal-title":"Infect Genet Evol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"111975","DOI":"10.1016\/j.msec.2021.111975","volume":"123","author":"Davani F.","year":"2021","unstructured":"Davani F.; Alishahi M.; Sabzi M.; Khorram M.; Arastehfar A.; Zomorodian K.; Dual drug delivery of vancomycin and imipenem\/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections. Mater Sci Eng C 2021,123,111975","journal-title":"Mater Sci Eng C"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.dsx.2021.06.010","volume":"15","author":"Fadol E.M.","year":"2021","unstructured":"Fadol E.M.; Suliman H.M.; Osman B.; Therapeutic outcomes evaluation of adjuvant hyperbaric oxygen therapy for non-healing diabetic foot ulcers among Sudanese patients. Diabetes Metab Syndr 2021,15(4),102173","journal-title":"Diabetes Metab Syndr"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jot.2021.04.006","volume":"29","author":"Yuan Y.","year":"2021","unstructured":"Yuan Y.; Ding X.; Jing Z.; Modified tibial transverse transport technique for the treatment of ischemic diabetic foot ulcer in patients with type 2 diabetes. J Orthop Translat 2021,29,100-105","journal-title":"J Orthop Translat"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.matpr.2021.01.376","volume":"43","author":"Suresh T.C.","year":"2021","unstructured":"Suresh T.C.; Poonguzhali T.V.; Anuradha V.; Ramesh B.; Suresh G.; Aqueous extract of Turbinaria conoides (J. Agardh) kutzing mediated fabrication of silver nanoparticles used against bacteria associated with diabetic foot ulcer. Mater Today Proc 2021,43(5),3038-3043","journal-title":"Mater Today Proc"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40265-020-01415-8","volume":"81","author":"Dixon D.","year":"2021","unstructured":"Dixon D.; Edmonds M.; Managing diabetic foot ulcers: Pharmacotherapy for wound healing. Drugs 2021,81(1),29-56","journal-title":"Drugs"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e1900362","DOI":"10.1002\/mabi.201900362","volume":"20","author":"Alavi M.","year":"2020","unstructured":"Alavi M.; Nokhodchi A.; Antimicrobial and wound treatment aspects of micro- and nanoformulations of carboxymethyl, dialdehyde, and TEMPO-oxidized derivatives of cellulose: Recent advances. Macromol Biosci 2020,20(4),e1900362","journal-title":"Macromol Biosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/IJGM.S278574","volume":"13","author":"Anwar K.","year":"2020","unstructured":"Anwar K.; Hussein D.; Salih J.; Antimicrobial susceptibility testing and phenotypic detection of MRSA isolated from diabetic foot infection. Int J Gen Med 2020,13,1349-1357","journal-title":"Int J Gen Med"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"e0244306","DOI":"10.1371\/journal.pone.0244306","volume":"15","author":"Alhubail A.","year":"2020","unstructured":"Alhubail A.; Sewify M.; Messenger G.; Microbiological profile of diabetic foot ulcers in Kuwait. PLoS One 2020,15(12),e0244306","journal-title":"PLoS One"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666220228161608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201513\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666220228161608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:46:50Z","timestamp":1685083610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201513\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399818666220228161608","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e280222201513"}}